
WB analysis of various samples using GTX11661 Presenilin 2 antibody. Lane 1 : rat brain tissue lysate Lane 2 : rat brain tissue lysate Lane 3 : MCF-7 cell lysate Lane 4 : HeLa cell lysate Lane 5 : SMMC cell lysate Lane 6 : CEM cell lysate
Presenilin 2 antibody
GTX11661
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetPSEN2
Overview
- SupplierGeneTex
- Product NamePresenilin 2 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 0.1-0.5microg/ml. IHC-P: 0.5-1microg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration500 ug/ml
- ConjugateUnconjugated
- Gene ID5664
- Target namePSEN2
- Target descriptionpresenilin 2
- Target synonymsAD3L, AD4, CMD1V, PS2, STM2, presenilin-2, AD3LP, AD5, Alzheimer disease 3-like, Alzheimer disease 4, E5-1, PS-2, STM-2
- HostRabbit
- IsotypeIgG
- Protein IDP49810
- Protein NamePresenilin-2
- Scientific DescriptionAlzheimers disease (AD) patients with an inherited form of the disease carry mutations in the presenilin proteins (PSEN1 or PSEN2) or the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form of amyloid-beta (main component of amyloid deposits found in AD brains). Presenilins are postulated to regulate APP processing through their effects on gamma-secretase, an enzyme that cleaves APP. Also, it is thought that the presenilins are involved in the cleavage of the Notch receptor such that, they either directly regulate gamma-secretase activity, or themselves act are protease enzymes. Two alternatively spliced transcript variants encoding different isoforms of PSEN2 have been identified. [provided by RefSeq, Jul 2008]
- ReactivityHuman, Mouse, Rat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC41116161
References
- BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors.Read this paper







